MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
J15 · Effective Jul 25, 2021
11 active Medicare policies list Z19.2, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Jul 25, 2021
JE · Effective Jul 4, 2021
JF · Effective Jul 4, 2021
J5 · Effective Jul 25, 2021
J8 · Effective Jul 25, 2021
JJ · Effective Jul 25, 2021
JM · Effective Jul 25, 2021
National · Effective Jun 2, 2022
National · Effective Nov 16, 2023
4 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Z19.2 |
|---|---|---|
| Gamma Glutamyl Transferase Testing | Jul 1, 2026 | Covered |
| Outpatient Laboratory-based Blood Glucose Testing | Jul 1, 2026 | Covered |
| Outpatient Urine Culture | Jan 6, 2026 | Covered |
| Thyroid Testing | Apr 15, 2026 | Covered |
National · Effective Feb 5, 2026
J5 · Effective May 28, 2026